최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기大韓韓方小兒科學會誌 = The journal of pediatrics of Korean medicine, v.29 no.3, 2015년, pp.54 - 64
차호열 (부산대학교한방병원 한방소아과) , 정아람 (부산대학교한방병원 한방소아과) , 천진홍 (부산대학교한방병원 한방소아과) , 안상현 (동국대학교 한의과대학 해부학교실) , 박선영 (세명대학교 한의과대학 생리학교실) , 김기봉 (부산대학교한방병원 한방소아과)
Objectives : This study was to investigate the anti-oxidative and anti-inflammatory effect of Lonicera japonica water extracts (LE) on Ulcerative Colitis Induced by DSS (Dextran Sulfate Sodium) in Mice. Methods : Colitis was induced by DSS in Balb/c mice. The sample group was divided into three. The...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
한의학에서 염증성 장질환은 어떤 범주에 해당하는가? | 한의학에서 염증성 장질환은 만성적인 혈변과 복통, 설사가 주증상이라는 점에서 腸澼, 便血, 腸風, 腸毒, 腹痛, 積聚, 休息痢, 久痢, 久瀉 등의 범주에 해당한다고 볼 수 있다. 국내에서 염증성 장질환에 대한 한약 처방의 치험례 및 DSS (Dextran Sulfate Sodium)로 유발된 대장염 동물모델에 대한 한약 처방의 실험적 효과가 발표된 바 있으나15) 이에 대한 기전 연구가 뒷받침되지 못하여 치료제 개발로는 이어지지 못하고 있다. | |
궤양성 대장염은 무엇인가? | 궤양성 대장염 (ulcerative colitis, UC)은 대장의 점막 또는 점막하층에 국한된 염증을 특징으로 하는 원인불명의 만성 염증성 장질환으로, 호전과 악화가 반복되는 혈성 설사와 대변급박감 (urgency) 및 복통 등을 주 증상으로 한다1,2). 궤양성 대장염은 유전적, 환경적 요인이 복합적으로 작용하여 발생하며, 환자는 전 세계적으로 분포하지만 북미와 북유럽에서 가장 호발한다. | |
국내 궤양성 대장염 유병률의 연령별, 성별 특징은 무엇인가? | 87명 정도로 추정된다8). 발병연령은 서양연구와 같이 젊은 나이에 흔하며, 20-40대의 연령에서 가장 빈도가 높다9). 남녀비는 1 : 1.1-1.3으로 여성이 약간 더 많다10). 국내 궤양성 대장염 환자의 1. |
Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371-85.
Su C, Lichtenstein GR. Ulcerative colitis. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. Volume 2. 8th ed. Philadelphia: Saunders. 2006:2499-548.
Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001;7:260-70.
Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol. 2006;12:6102-08.
Kim SJ, Cho YK, Rhee JE, Yoon CM. Two cases of ulcerative colitis. Korean J Gastroenterol. 1970;2:29-31.
Kwon KH, Park CS, Kim BR, Kim CK. A clinical review of ulcerative colitis. Korean J Gastroenterol. 1984;16:121-7.
Yang SK, Song IS, Kim YH, Kim HY, Park ER, Kim KJ, Park JB, Yang SH, Kim JW, Myung SJ, Kim JH, Min YI. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2001. Gastroenterology. 2003;124(suppl)(abstr):210A.
Yang SK, Yun SC, Kim JH, Park JY, Kim HY, Kim YH, Chang DK, Kim JS, Song IS, Park JB, Park ER, Kim KJ, Moon G, Yang SH. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis. 2008;14:542-9.
Lee CR, Suh JH, Hahn CH, Chung HW, Lee HW, Lee JH, Choi CH, Kim WH. Characteristics of ulcerative colitis according to the age of onset. Korean J Gastroenterol. 2001;37:196-202.
Yang SH. Current status and clinical characteristics of inflammatory bowel disease in Korea. Korean J Gastroenterol. 2002;40:1-14.
Park JB, Yang SK, Byeon JS. Familial occurrence of inflammatory bowel disease in Korea. Inflamm Bowel Dis. 2006;12:1146-51.
Su C, Lewis JD, Goldberg B, Brensinger C, Lichtenstein GR. A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis. Gastroenterology. 2007;132:516-26.
Choi CH, Kim YH, Kim YS, Ye BD, Lee KM, Lee BI, Jung SA, Kim WH, Lee HY. Guidelines for the Management of Ulcerative Colitis. Korean J Gastroenterol. 2012;59(2):118-40.
Jeen YT, Kim JH. Advances in ulcerative colitis therapy. Korean J Med. 2009;76(6):654-60.
Kim SY, Park JW, Ryu BH. Effects of Auklandia lappa on dextran sulfate sodium-induced murine colitis. Korean J Orient Int Med. 2013;34(2):134-46.
Kim IL, Kim HC, Kook YB, Park SJ, Park YG, Park GH, Seo BI, Seo YB, Song H J, Shin MK, Lee YJ, Lee YC, Lee JH, Lim GH, Cho SI, Jeong JK, Zoo YS, Choi HY. Herbal medicine. Seoul: Young lim publishing Co. 2007:240-2.
Kim Y, Yang SY, Oh YS, Lee JW, Lee YK, Park YC. Research trends of Lonicera japonica over the last 10 year. J Daejeon Orient Med. 2010;19:17-23.
Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004;287(1):G7-17.
Fazio V. Current status of surgery for inflammatory bowel disease. Digestion. 1998;59(5):470-80.
Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res. 2001;1:480-1.
Ishiguro K, Ando T, Maeda O, Hasegawa M, Kadomatsu K, Ohmiya N, Niwa Y, Xavier R, Goto H. Paeonol attenuates TNBS-induced colitis by inhibiting NF-B and STAT1 transactivation. Toxicol Appl Pharmacol. 2006;217(1):35-42.
Anggard E. Nitric oxide: mediator, murderer, and medicine. Lancet. 1994;9:1199-206.
Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN, Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998;93(5):705-16.
Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 1994;269(7):4705-8.
Barnes PJ, Karin MN. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. Engl J Med. 1997;336(15):1066-71.
Baeuerle PA. $I{\kappa}B-NF-{\kappa}B$ structure: at the interface of inflammation control. Cell. 1998;95:729-31.
Kim HS, Berstad A. Experimental colitis in animal models. Scand J Gastroenterol. 1992;27(7):529-37.
Frank K, Helmut M, Marianne A, Volker G, Tina B, Jurgen S, Josef R. Clinical and histopathological features of dextran sulfate sodium induced acute and chronic colitis associated with dysplasia in rats. Int J Colorectal Dis. 2001;16:238-46.
Ishioka T, Kuwabara N, Oohashi Y, Wakabayashi K. Induction of colorectal tumors in rats by sulfated polysaccharides. Crit Rev Toxicol. 1987;17:215-44.
Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya RA. Novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694-702.
Gassler N, Rohr C, Schneider A, Kartenbeck J, Bach A, Obermuller N, Otto HF, Autschbach. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol. 2001;281(1):G216-28.
Melgar S, Engstroom K, Jaagervall A, Martinez V. Psychological stress reactivates dextran sulfate sodium-induced chronic colitis in mice. Stress. 2008;11:348-62.
Gonzalez MF, Shiraishi K, Hisanaga K, Sagar SM, Mandabach M, Sharp FR. Heat shock protein as markers of neuronal injury. Mol Brain Res. 1989;6:93-100.
Groszmann RJ. Hyperdynamic state in chronic liver diseases. J Hepatol. 1993;17(2):S38-40.
RothkOtter HJ, Pabst P, Bailey M. Lymphocyte migration in the intestinal mucosa : entry, transit and emigration of lymphoid cells and the influence of antigen. Vetrinary Immuno Immunopath. 1999;72:157-65.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.